José Alcamı́

10.6k total citations
211 papers, 6.9k citations indexed

About

José Alcamı́ is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, José Alcamı́ has authored 211 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Virology, 84 papers in Infectious Diseases and 79 papers in Immunology. Recurrent topics in José Alcamı́'s work include HIV Research and Treatment (147 papers), HIV/AIDS drug development and treatment (61 papers) and Immune Cell Function and Interaction (46 papers). José Alcamı́ is often cited by papers focused on HIV Research and Treatment (147 papers), HIV/AIDS drug development and treatment (61 papers) and Immune Cell Function and Interaction (46 papers). José Alcamı́ collaborates with scholars based in Spain, France and United States. José Alcamı́'s co-authors include Mayte Coiras, María Rosa López‐Huertas, Luis M. Bedoya, Jesús Gil, Mariano Estéban, Françoise Bachelerie, Mayte Pérez‐Olmeda, Javier García‐Pérez, Sonsoles Sánchez‐Palomino and F Arenzana-Seisdedos and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

José Alcamı́

206 papers receiving 6.7k citations

Peers

Countries citing papers authored by José Alcamı́

Since Specialization

Citations

This map shows the geographic impact of José Alcamı́'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Alcamı́ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Alcamı́ more than expected).

Fields of papers citing papers by José Alcamı́

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Alcamı́. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Alcamı́. The network helps show where José Alcamı́ may publish in the future.

Co-authorship network of co-authors of José Alcamı́

This figure shows the co-authorship network connecting the top 25 collaborators of José Alcamı́. A scholar is included among the top collaborators of José Alcamı́ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Alcamı́. José Alcamı́ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size 2025 ·International Journal of Molecular Sciences ·Erick De La Torre Tarazona, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Teresa Aldámiz‐Echevarría, (unknown), Cristina Moreno, (unknown), Juan Tiraboschi, Sergio Reus, José Alcamı́, Sergio Serrano‐Villar, Santiago Moreno, (unknown)	0
2	Novel HIV-1 RNA biogenesis inhibitors identified by virtual pharmacophore-based screening 2023 ·Biochemical Pharmacology ·(unknown), José Alcamı́, Manuela Beltrán, Luis M. Bedoya, José Gallego	2
3	Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging 2023 ·Pharmaceutics ·(unknown), Víctor Casanova, Judith Grau-Expósito, Sonsoles Sánchez‐Palomino, José Alcamı́, Núria Climent	12
4	Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection 2022 ·Journal of Clinical Medicine ·(unknown), (unknown), Sara Rodríguez-Mora, Javier García‐Pérez, Magdalena Corona, (unknown), (unknown), Gemma Moreno, Montserrat Torres, Elena Mateos, (unknown), José Alcamı́, Mayte Pérez‐Olmeda, Javier López‐Jiménez, Valentín García‐Gutiérrez, Mayte Coiras, (unknown)	2
5	The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans 2022 ·iScience ·Carolina Herrera, Mackenzie L. Cottrell, (unknown), Angela D. M. Kashuba, Ronald S. Veazey, Javier García‐Pérez, Natalia Olejniczak, Clare F. McCoy, Paul Ziprin, Nicola Richardson‐Harman, José Alcamı́, Karl Malcolm, Robin J. Shattock	3
6	Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster 2022 ·Cancers ·Montserrat Torres, Magdalena Corona, Sara Rodríguez-Mora, (unknown), (unknown), Elena Mateos, (unknown), (unknown), (unknown), Javier García‐Pérez, José Alcamı́, Mayte Pérez‐Olmeda, Mayte Coiras, Javier López‐Jiménez, Valentín García‐Gutiérrez, (unknown)	1
7	Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19 2022 ·Journal of Clinical Medicine ·Sara Rodríguez-Mora, Magdalena Corona, Montserrat Torres, (unknown), Javier García‐Pérez, (unknown), (unknown), (unknown), Elena Mateos, Fernando Martín‐Moro, (unknown), (unknown), José Alcamı́, Mayte Pérez‐Olmeda, Javier López‐Jiménez, Valentín García‐Gutiérrez, Mayte Coiras, (unknown)	5
8	Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals 2021 ·Vaccines ·Csaba Fehér, (unknown), Lorna Leal, Montserrat Plana, Mireia Arnedo, Henk‐Jan van den Ham, Arno C. Andeweg, Rob A. Gruters, Francisco Díez‐Fuertes, José Alcamı́, Patrick Aloy, Felipe García	2
9	Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses 2021 ·Journal of Virology ·(unknown), Ilja Bontjer, Núria Gonzàlez, María Pernas, (unknown), Àlex Olvera, José M. Miró, Christian Brander, José Alcamı́, Rogier W. Sanders, Víctor Sánchez-Merino, Eloísa Yuste	10
10	Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine 2021 ·Vaccines ·(unknown), Francisco Díez‐Fuertes, Sonsoles Sánchez‐Palomino, José Alcamı́, Montserrat Plana, David Torrents, Lorna Leal, Felipe García	11
11	Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission 2020 ·Journal of Clinical Medicine ·(unknown), Alejandro Luna, Miguel Á. Galán, Sara Rodríguez-Mora, (unknown), Elena Mateos, Miguel Piris‐Villaespesa, Guiomar Bautista, Esther San José, José Rivera, Juan Luis Steegmann, Fernando de Ory, Mayte Pérez‐Olmeda, José Alcamı́, Vicente Planelles, María Rosa López‐Huertas, Valentín García‐Gutiérrez, Mayte Coiras	17
12	PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients 2020 ·Journal of Clinical Investigation ·Julien Pothlichet, Thierry Rose, (unknown), Louise Jeammet, Annalisa Meola, (unknown), Frederick Saul, David Gény, José Alcamı́, Ezequiel Ruíz-Mateos, Luc Teyton, Gérard Lambeau, Jacques Thèze	24
13	The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection 2019 ·PLoS Pathogens ·Sara Rodríguez-Mora, (unknown), Javier García‐Pérez, Mercedes Bermejo, María Rosa López‐Huertas, Elena Mateos, Pilar Martí, Susana Rocha, (unknown), Frauke Christ, Zeger Debyser, Juan J. Vílchez, Mayte Coiras, José Alcamı́	17
14	Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers 2018 ·Journal of Virology ·Míriam Rosás-Umbert, Anuska Llano, Rocío Bellido, Àlex Olvera, Marta Ruiz‐Riol, Muntsa Rocafort, Marco A. Fernández, Patricia Cobarsí, Manel Crespo, Lucy Dorrell, Jorge del Romero, José Alcamı́, Roger Paredes, Christian Brander, Beatriz Mothe	30
15	Environmentally Friendly Procedure Based on Supercritical Fluid Chromatography and Tandem Mass Spectrometry Molecular Networking for the Discovery of Potent Antiviral Compounds from Euphorbia semiperfoliata 2017 ·Journal of Natural Products ·Louis‐Félix Nothias, Stéphanie Boutet‐Mercey, Xavier Cachet, (unknown), (unknown), Jean‐François Gallard, Pascal Retailleau, Alain Brunelle, Pieter C. Dorrestein, Jean Costa, Luis M. Bedoya, Fanny Roussi, Pieter Leyssen, José Alcamı́, Julien Paolini, Marc Litaudon, David Touboul	49
16	HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines 2013 ·Proceedings of the National Academy of Sciences ·Philippe Colin, Yann Bénureau, Isabelle Staropoli, Yongjin Wang, Núria Gonzàlez, José Alcamı́, Oliver Hartley, Anne Brelot, Fernando Arenzana‐Seisdedos, Bernard Lagane	51
17	SDF-1/CXCL12 Production by Mature Dendritic Cells Inhibits the Propagation of X4-Tropic HIV-1 Isolates at the Dendritic Cell-T-Cell Infectious Synapse 2010 ·Journal of Virology ·Núria Gonzàlez, Mercedes Bermejo, Esther Calonge, Clare Jolly, Fernando Arenzana‐Seisdedos, José L. Pablos, Quentin J. Sattentau, José Alcamı́	18
18	Inmunopatología del sida 2001 ·Medicina integral: Medicina preventiva y asistencial en atención primaria de la salud ·José Alcamı́, Joaquín Rullás, Mercedes Bermejo, Manuela Beltrán, (unknown)	0
19	Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains 1998 ·European Journal of Immunology ·Mercedes Bermejo, Juan Martin‐Serrano, Estelle Oberlin, (unknown), Antonio Serrano, Begoña Santiago, Antonio Carúz, Pius Loetscher, Marco Baggiolini, (unknown), José Alcamı́	2
20	Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains 1998 ·European Journal of Immunology ·Mercedes Bermejo, Juan Martin‐Serrano, Estelle Oberlin, (unknown), Antonio Serrano, Begoña Santiago, Antonio Carúz, Pius Loetscher, Marco Baggiolini, (unknown), José Alcamı́	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact